What is INDV's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 4.18B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for INDV?

P/E (TTM) is 11.81 and 52-week range is $22.95 to $42.81 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s INDV figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for INDV?

The company profile lists revenue (TTM) near $1.30B, net income (TTM) near $346M, EPS (TTM) near $2.78 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Indivior Pharmaceuticals, Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Slough, Virginia, US, 121M shares outstanding, ISIN US45579U1097 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Indivior Pharmaceuticals, Inc

$INDV

Health Care · Pharmaceuticals

IR Run Scenarios

$35.42

-1.77%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The firm provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The company sells its products in the United States and in other selected areas of the world.

Employees

827

Website

www.indivior.com/

IPO

2023-06-12

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)